Assessment of Efficiency of Antianemic Therapy in Pregnant Women Suffering from Anemia
Abstract
Nowadays iron-states are a nationwide problem of health care systems in different countries, most often occurring among pregnant women and in early childhood. Iron supplements play leading role in the treatment of this pathology, and for decades of practical application, they have undergone a number of changes. Research efforts are aimed to increase their therapeutic efficiency and reduce the number and severity of side effects. The most modern group of antianemic drugs are non-ionic iron preparations, which represented by Ferrofer. The article discusses the advantages of treatment with combined Ferro therapy with REPO and over using only iron supplement, namely, high efficiency, rapid achievement of the effect, safety, the presence of various forms of release. These features allow to recommend Combination of Ferro and REPO therapy as the primary therapy of iron deficiency anemia in a broad range of patients, including pregnant women, and its effective use in anemia of various severity.